MedPath
FDA Approval

FENTANYL

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Apotex Corp.
DUNS: 845263701
Effective Date
July 13, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Fentanyl(37.5 ug in 1 h)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Aveva Drug Delivery Systems Inc.

Apotex Corp.

783982093

Products12

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

FENTANYL

Product Details

NDC Product Code
60505-7015
Application Number
ANDA077449
Marketing Category
ANDA (C73584)
Route of Administration
TRANSDERMAL
Effective Date
July 13, 2023
ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJSClass: IACT
OCTYLDODECANOLInactive
Code: 461N1O614YClass: IACT
FentanylActive
Code: UF599785JZClass: ACTIBQuantity: 37.5 ug in 1 h
POLYBUTENE (1400 MW)Inactive
Code: 1NA5AO9GH7Class: IACT
POLYISOBUTYLENE (800000 MW)Inactive
Code: Y132ZOQ9H7Class: IACT

FENTANYL

Product Details

NDC Product Code
60505-7007
Application Number
ANDA077449
Marketing Category
ANDA (C73584)
Route of Administration
TRANSDERMAL
Effective Date
July 13, 2023
ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJSClass: IACT
POLYBUTENE (1400 MW)Inactive
Code: 1NA5AO9GH7Class: IACT
POLYISOBUTYLENE (800000 MW)Inactive
Code: Y132ZOQ9H7Class: IACT
OCTYLDODECANOLInactive
Code: 461N1O614YClass: IACT
FentanylActive
Code: UF599785JZClass: ACTIBQuantity: 50 ug in 1 h

FENTANYL

Product Details

NDC Product Code
60505-7011
Application Number
ANDA077449
Marketing Category
ANDA (C73584)
Route of Administration
TRANSDERMAL
Effective Date
July 13, 2023
ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJSClass: IACT
POLYISOBUTYLENE (800000 MW)Inactive
Code: Y132ZOQ9H7Class: IACT
POLYBUTENE (1400 MW)Inactive
Code: 1NA5AO9GH7Class: IACT
OCTYLDODECANOLInactive
Code: 461N1O614YClass: IACT
FentanylActive
Code: UF599785JZClass: ACTIBQuantity: 25 ug in 1 h

FENTANYL

Product Details

NDC Product Code
60505-7006
Application Number
ANDA077449
Marketing Category
ANDA (C73584)
Route of Administration
TRANSDERMAL
Effective Date
July 13, 2023
ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJSClass: IACT
OCTYLDODECANOLInactive
Code: 461N1O614YClass: IACT
POLYBUTENE (1400 MW)Inactive
Code: 1NA5AO9GH7Class: IACT
FentanylActive
Code: UF599785JZClass: ACTIBQuantity: 25 ug in 1 h
POLYISOBUTYLENE (800000 MW)Inactive
Code: Y132ZOQ9H7Class: IACT

FENTANYL

Product Details

NDC Product Code
60505-7013
Application Number
ANDA077449
Marketing Category
ANDA (C73584)
Route of Administration
TRANSDERMAL
Effective Date
July 13, 2023
POLYISOBUTYLENE (800000 MW)Inactive
Code: Y132ZOQ9H7Class: IACT
FentanylActive
Code: UF599785JZClass: ACTIBQuantity: 75 ug in 1 h
OCTYLDODECANOLInactive
Code: 461N1O614YClass: IACT
ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJSClass: IACT
POLYBUTENE (1400 MW)Inactive
Code: 1NA5AO9GH7Class: IACT

FENTANYL

Product Details

NDC Product Code
60505-7016
Application Number
ANDA077449
Marketing Category
ANDA (C73584)
Route of Administration
TRANSDERMAL
Effective Date
July 13, 2023
ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJSClass: IACT
OCTYLDODECANOLInactive
Code: 461N1O614YClass: IACT
POLYBUTENE (1400 MW)Inactive
Code: 1NA5AO9GH7Class: IACT
POLYISOBUTYLENE (800000 MW)Inactive
Code: Y132ZOQ9H7Class: IACT
FentanylActive
Code: UF599785JZClass: ACTIBQuantity: 62.5 ug in 1 h

FENTANYL

Product Details

NDC Product Code
60505-7008
Application Number
ANDA077449
Marketing Category
ANDA (C73584)
Route of Administration
TRANSDERMAL
Effective Date
July 13, 2023
ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJSClass: IACT
OCTYLDODECANOLInactive
Code: 461N1O614YClass: IACT
POLYBUTENE (1400 MW)Inactive
Code: 1NA5AO9GH7Class: IACT
POLYISOBUTYLENE (800000 MW)Inactive
Code: Y132ZOQ9H7Class: IACT
FentanylActive
Code: UF599785JZClass: ACTIBQuantity: 75 ug in 1 h

FENTANYL

Product Details

NDC Product Code
60505-7009
Application Number
ANDA077449
Marketing Category
ANDA (C73584)
Route of Administration
TRANSDERMAL
Effective Date
July 13, 2023
ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJSClass: IACT
OCTYLDODECANOLInactive
Code: 461N1O614YClass: IACT
FentanylActive
Code: UF599785JZClass: ACTIBQuantity: 100 ug in 1 h
POLYBUTENE (1400 MW)Inactive
Code: 1NA5AO9GH7Class: IACT
POLYISOBUTYLENE (800000 MW)Inactive
Code: Y132ZOQ9H7Class: IACT

FENTANYL

Product Details

NDC Product Code
60505-7010
Application Number
ANDA077449
Marketing Category
ANDA (C73584)
Route of Administration
TRANSDERMAL
Effective Date
July 13, 2023
POLYISOBUTYLENE (800000 MW)Inactive
Code: Y132ZOQ9H7Class: IACT
ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJSClass: IACT
OCTYLDODECANOLInactive
Code: 461N1O614YClass: IACT
POLYBUTENE (1400 MW)Inactive
Code: 1NA5AO9GH7Class: IACT
FentanylActive
Code: UF599785JZClass: ACTIBQuantity: 12 ug in 1 h

FENTANYL

Product Details

NDC Product Code
60505-7017
Application Number
ANDA077449
Marketing Category
ANDA (C73584)
Route of Administration
TRANSDERMAL
Effective Date
July 13, 2023
ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJSClass: IACT
OCTYLDODECANOLInactive
Code: 461N1O614YClass: IACT
POLYBUTENE (1400 MW)Inactive
Code: 1NA5AO9GH7Class: IACT
FentanylActive
Code: UF599785JZClass: ACTIBQuantity: 87.5 ug in 1 h
POLYISOBUTYLENE (800000 MW)Inactive
Code: Y132ZOQ9H7Class: IACT
Showing 1 to 10 of 12 products

Drug Labeling Information

Complete FDA-approved labeling information including indications, dosage, warnings, contraindications, and other essential prescribing details.

RECENT MAJOR CHANGES SECTION

Highlight: Dosage and Administration ( 2) 1/2018

Boxed Warning 09/2018

Warnings and Precautions ( 5.2) 09/2019

RECENT MAJOR CHANGES

Dosage and Administration ( 2) 1/2018

Boxed Warning 09/2018

Warnings and Precautions ( 5.2) 09/2019


© Copyright 2025. All Rights Reserved by MedPath